Investing.com - Financial Markets Worldwide
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Fortress Biotech Inc (FBIO)

NASDAQ
Symbol
Exchange
Currency
FBIONASDAQUSD
FBIOPNASDAQUSD
Currency in USD
Disclaimer
1.7800
-0.0900(-4.81%)
Closed
After Hours
1.7600-0.0200(-1.1236%)

FBIO Comments

ATXI will soon announce c11 , will see how fbio reacts.. bit they could decide to delist within this year
lol , what a mess... now even non compliance with Nasdaq... dead play
and precise $1 today maybe some first position now
Someone big entered or shortsellers are closing positions?
told you to wait for 1 dollar
I bet it is riggt now the most short sold stock.....i wosh some good new can brake the plot.
1 is getting closer 😬
as I imagined.. area 1.5 and now towards $1
I bet we are done, closed an old gap, i bought stocks again today
you need to be patient and careful... $1 is almost inevitable
complete disaster
Someone is eagerly buying at this price...
that's not me
as I said... avoid as *****.. arounf 1/1.5 I will considernfor speculation
Tramadol finally refused? Can you close this unfruitful chapter??
This is Ready for a good run, bought for $2 , I'm waiting for a run to the north, there are catalysts for the near future, with this breakthrough attempt it can go crazy.
This stock follows itself, close gap and break up with no reason....i just wait to have a drug approval and i m out, i dont like this way of handling company.
exactly.. and tbh recent news are not that great at all... being a bio aggregate, well... you always need to analyse risk/rewards
were you saying?
back to $1
Told you Ale... never hang so long in a penny stock and managed by an ex Wall street guy... I sold at $6 last Spring and never looked back, just waiting for the gap closed and then still observing... maybe now..
Fk, they expect to complete FDA review of cyprium therapeutics in mid-2022, so after Tramadol last review....fk fk fk.
Now 2.5 seems a resistence...such a bad sign.
so now it will stabilize looking for support to restart a decent pattern
They are so predictable, go for support as soon as SEP500 drop consistently, big crash for no reason linked to company.
tomorrow gap closed then we will evaluate..
Nice, FDA will discuss again IV tramadol on 15th february 2022, if i am lucky we will get approval for menkes disease treatment before and i will happily sell my stocks, tramadol approval is such a mess.
..and here comes the 2.5 gap ...
News about tramadol. They asked a meeting with new drug committee of FDA to reconsider the drug approval, a final response is due in next 30 days.
I can't find news on Intravenous (IV) tramadolPostoperative pain following bunionectomy surgery, what is happened? Is it over?¿
Yes.
I mean you do realize that deal was peanuts and that soon ATXI will go in Chapter 11, right?
Maybe you are right. However, i invested in Fbio looking for cyprium drug approval and won t sell before that, i hope it is the right thing, future will tell us.
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.